Cargando…
Interassay and interobserver comparability study of four programmed death-ligand 1 (PD-L1) immunohistochemistry assays in triple-negative breast cancer
Different immunohistochemical programmed death-ligand 1 (PD-L1) assays and scorings have been reported to yield variable results in triple-negative breast cancer (TNBC). We compared the analytical concordance and reproducibility of four clinically relevant PD-L1 assays assessing immune cell (IC) sco...
Autores principales: | Noske, Aurelia, Wagner, Daniel-Christoph, Schwamborn, Kristina, Foersch, Sebastian, Steiger, Katja, Kiechle, Marion, Oettler, Dirk, Karapetyan, Siranush, Hapfelmeier, Alexander, Roth, Wilfried, Weichert, Wilko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602040/ https://www.ncbi.nlm.nih.gov/pubmed/34768219 http://dx.doi.org/10.1016/j.breast.2021.11.003 |
Ejemplares similares
-
Risk stratification in luminal-type breast cancer: Comparison of Ki-67 with EndoPredict test results
por: Noske, Aurelia, et al.
Publicado: (2019) -
First prospective outcome data for the second-generation multigene test Endopredict in ER-positive/HER2-negative breast cancer
por: Ettl, Johannes, et al.
Publicado: (2020) -
Cross-species and interassay comparisons of phytoestrogen action.
por: Whitten, P L, et al.
Publicado: (2001) -
SARS-CoV-2 infection and cardiovascular or pulmonary complications in ambulatory care: A risk assessment based on routine data
por: Karapetyan, Siranush, et al.
Publicado: (2021) -
Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variability
por: Harenberg, Job, et al.
Publicado: (2011)